October 7, 2024
OncoBone Ltd has received a significant funding package from a loan instrument of Finnish government organization Finnvera, and from Nordea, the local bank of OncoBone Ltd in Finland.
The loan instrument is designed for internationalization of Finnish companies, and it is earmarked for business development of companies registered outside Finland who are significant shareholders in a company in Finland, or in which a Finnish company is a significant shareholder.
OncoBone Ltd will further lend the funds to OncoBone Therapeutics Ltd based in London, UK (formerly known as OncoBone Ventures) for business development and advancing its preclinical-stage therapeutic assets. OncoBone Ltd is a significant shareholder of OncoBone Therapeutics.
For more information about OncoBone Therapeutics, please visit their webpages at https://www.oncobonetherapeutics.com/.
If you are interested to learn more,
see our services or contact us directly.
